These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 15338883

  • 21. Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.
    Liu J, Kopečková P, Pan H, Sima M, Bühler P, Wolf P, Elsässer-Beile U, Kopeček J.
    Macromol Biosci; 2012 Mar; 12(3):412-22. PubMed ID: 22493797
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates.
    Yuan F, Qin X, Zhou D, Xiang QY, Wang MT, Zhang ZR, Huang Y.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):770-6. PubMed ID: 18656539
    [Abstract] [Full Text] [Related]

  • 24. [Studies on lung targeting gelatin microspheres of mitoxantrone].
    Wang JH, Lu B, Xu PL, Bao DY, Zhang ZR.
    Yao Xue Xue Bao; 1995 Nov; 30(7):549-55. PubMed ID: 7484159
    [Abstract] [Full Text] [Related]

  • 25. [Study on pharmacokinetics of mitoxantrone polycyanoacrylate nanoparticles freeze-dried injection by HPLC column switching technique].
    Zhang ZR, Liao GT, Ye LM.
    Yao Xue Xue Bao; 1995 Nov; 30(11):843-7. PubMed ID: 8712010
    [Abstract] [Full Text] [Related]

  • 26. Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.
    Mitra A, Coleman T, Borgman M, Nan A, Ghandehari H, Line BR.
    J Control Release; 2006 Aug 28; 114(2):175-83. PubMed ID: 16889865
    [Abstract] [Full Text] [Related]

  • 27. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T, Subr V, Strohalm J, Sírová M, Ríhová B, Ulbrich K.
    J Control Release; 2012 Dec 28; 164(3):346-54. PubMed ID: 22759979
    [Abstract] [Full Text] [Related]

  • 28. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F.
    J Control Release; 2001 Jul 06; 74(1-3):135-46. PubMed ID: 11489490
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.
    Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Huber P, Hennink W, Storm G.
    Neoplasia; 2006 Oct 06; 8(10):788-95. PubMed ID: 17032495
    [Abstract] [Full Text] [Related]

  • 31. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
    Zhou Z, Xu X, Li L, Huang Y.
    J Drug Target; 2015 Oct 06; 23(9):821-31. PubMed ID: 25830626
    [Abstract] [Full Text] [Related]

  • 32. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
    Kunath K, Kopecková P, Minko T, Kopecek J.
    Eur J Pharm Biopharm; 2000 Jan 06; 49(1):11-5. PubMed ID: 10613922
    [Abstract] [Full Text] [Related]

  • 33. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.
    Mitra A, Nan A, Ghandehari H, McNeill E, Mulholland J, Line BR.
    Pharm Res; 2004 Jul 06; 21(7):1153-9. PubMed ID: 15290854
    [Abstract] [Full Text] [Related]

  • 34. Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems.
    Lammers T, Peschke P, Kühnlein R, Subr V, Ulbrich K, Debus J, Huber P, Hennink W, Storm G.
    J Control Release; 2007 Feb 26; 117(3):333-41. PubMed ID: 17215057
    [Abstract] [Full Text] [Related]

  • 35. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H, Etrych T, Ríhová B, Kostka L, Starovoytová L, Kovář M, Ulbrich K.
    Macromol Biosci; 2013 Dec 26; 13(12):1648-60. PubMed ID: 24031022
    [Abstract] [Full Text] [Related]

  • 36. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y, Xu J, Lin Y, Yu H, Gong T, Li Y, Zhang Z.
    J Biomed Mater Res A; 2008 Nov 26; 87(2):515-23. PubMed ID: 18186066
    [Abstract] [Full Text] [Related]

  • 37. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R, Hailu H, Davies JW, Summerford C, Duncan R.
    Bioconjug Chem; 2003 Nov 26; 14(4):797-804. PubMed ID: 12862433
    [Abstract] [Full Text] [Related]

  • 38. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
    Yeung TK, Hopewell JW, Simmonds RH, Seymour LW, Duncan R, Bellini O, Grandi M, Spreafico F, Strohalm J, Ulbrich K.
    Cancer Chemother Pharmacol; 1991 Nov 26; 29(2):105-11. PubMed ID: 1760851
    [Abstract] [Full Text] [Related]

  • 39. Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
    Duncan R, Kopecková P, Strohalm J, Hume IC, Lloyd JB, Kopecek J.
    Br J Cancer; 1988 Feb 26; 57(2):147-56. PubMed ID: 3358905
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.